TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/13 20:05 | 2/19/13 | AOLS | Aeolus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Xmark Opportunity Partners, LLC | CT | T | S.d | -592 | 0.3300 | 0 | -1,794 | -2 | 96,932 | I | |||||||||||||||
7/1/09 20:06 | 6/29/09 | GENR | Genaera Corp | DE | Health | BioPrd | Biological Products, (No Diag | Xmark Opportunity Partners, LLC | CT | T | S | -4 | 0.1015 | 0 | -43 | -1 | 2,796 | I | |||||||||||||||
6/9/09 20:37 | 6/5/09 | GENR | Genaera Corp | DE | Health | BioPrd | Biological Products, (No Diag | Xmark Opportunity Partners, LLC | CT | T | S | -427 | 0.3095 | 0 | -1,379 | -33 | 2,838 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |